Initial Strategies in Advanced HCC: Case 1
Initial Strategies in Advanced HCC
December 2014
- A 64-year old male positive with HCV presents to his PCP with nausea, vomiting, syncope
- ECOG=1
- Child-Pugh B
- T bilirubin 2.1; albumin 3.2; INR 1.1; no ascites, no encephalopathy; platelets 78
- CT scan revealed one 4-cm lesion in the liver
- No extrahepatic disease; no portal vein invasion
- Laboratory results: AFP=400 ng/ml
- Patient is within Milan criteria
- Bridge using TACE until liver transplantation
Recent Videos
Related Content
Gholam Contrasts Lenvatinib With Other Options in Child-Pugh B HCC
December 21st 2024Article
During a Case-Based Roundtable® event, Pierre Gholam, MD, discussed how post hoc and real-world analyses build upon the limited available trial data for treating patients with unresectable hepatocellular carcinoma with Child-Pugh B status.
Read More
FDA Accepts NDA Resubmission of Rivoceranib and Camrelizumab in HCC
October 21st 2024Article
The new drug application resubmission of rivoceranib/camrelizumab in the first line in unresectable or metastatic hepatocellular carcinoma is supported by the final survival analysis of CARES-310 trial.
Read More
